Context Therapeutics Inc. (CNTX) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts CNTX Hot Sheet
Join SI Premium – FREE
Context Therapeutics Inc. (NASDAQ: CNTX) reported Q3 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09).
For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Upgrades Hub Group (HUBG) to Outperform
- Morgan Stanley Upgrades Manhattan Associates (MANH) to Overweight
- UBS Starts Vylor Inc (VYLR) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
